StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)

Close on Nov 18, 2026Market cap $2.26MP/E –Yield –

DataMeds AI cash

Cash and short-term investments held at the end of each period.

DataMeds AI's cash was $476.60K at Sep 30, 2026. For fiscal 2025 it was $42.57K, down 95.9% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$42.57K-95.9%
FY2024Dec 31, 2024$1.03M+75291.2%
FY2023Dec 31, 2023$1.36K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$476.60K-88.7%
Q2 FY2026Jun 30, 2026$2.46M+484.9%
Q1 FY2026Mar 31, 2026$51.73K-97.9%
Q4 FY2025Dec 31, 2025$42.57K-95.9%
Q3 FY2025Sep 30, 2025$4.23M+309919.5%
Q2 FY2025Jun 30, 2025$419.94K–
Q1 FY2025Mar 31, 2025$2.52M–
Q4 FY2024Dec 31, 2024$1.03M–
Q4 FY2023Dec 31, 2023$1.36K–

More DataMeds AI figures

See a number that looks wrong?